We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+38.57%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$680B
AUM Growth
+$89.5B
Cap. Flow
-$28.8B
Cap. Flow %
-4.24%
Top 10 Hldgs %
21.1%
Holding
2,615
New
56
Increased
1,632
Reduced
714
Closed
86

Sector Composition

Rank Sector Weight
1 Technology 18.45%
2 Healthcare 18.09%
3 Consumer Discretionary 13.59%
4 Financials 13.39%
5 Communication Services 9.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BWA icon
1251
BorgWarner
BWA
$13.8B
$14.5M ﹤0.01%
428,791
+5,519
+1% +$191K
NWL icon
1252
Newell Brands
NWL
$2.63B
$14.3M ﹤0.01%
930,972
-42,325
-4% -$778K
EXTN
1253
DELISTED
Exterran Corporation
EXTN
$14.2M ﹤0.01%
841,877
-690
-0.1% -$12.3K
IVV icon
1254
iShares Core S&P 500 ETF
IVV
$910B
$14.1M ﹤0.01%
49,710
+28,551
+135% +$7.81M
FRPH icon
1255
FRP Holdings
FRPH
$425M
$14.1M ﹤0.01%
592,598
-87,178
-13% -$2.17M
CHCT
1256
Community Healthcare Trust
CHCT
$433M
$14M ﹤0.01%
+391,297
New +$13M
NFE icon
1257
New Fortress Energy
NFE
$93M
$14M ﹤0.01%
+1,196,895
New +$15.6M
PCRX icon
1258
Pacira BioSciences
PCRX
$924M
$14M ﹤0.01%
366,930
-717,082
-66% -$28M
M icon
1259
Macy's
M
$6.27B
$13.9M ﹤0.01%
578,623
+45,719
+9% +$1.15M
RGCO icon
1260
RGC Resources
RGCO
$226M
$13.9M ﹤0.01%
524,457
+18,705
+4% +$529K
SIBN icon
1261
SI-BONE Inc
SIBN
$849M
$13.8M ﹤0.01%
734,629
-13,760
-2% -$266K
FPRX
1262
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$13.7M ﹤0.01%
1,022,447
-10,871
-1% -$124K
FSS icon
1263
Federal Signal
FSS
$7.51B
$13.7M ﹤0.01%
525,473
+73,430
+16% +$1.68M
PLUS icon
1264
ePlus
PLUS
$2.31B
$13.6M ﹤0.01%
307,604
+107,704
+54% +$4.48M
GPK icon
1265
Graphic Packaging
GPK
$3.51B
$13.6M ﹤0.01%
1,074,088
-831,445
-44% -$10.1M
UNM icon
1266
Unum
UNM
$14.7B
$13.5M ﹤0.01%
400,325
+16,500
+4% +$574K
PHM icon
1267
Pultegroup
PHM
$24.9B
$13.5M ﹤0.01%
483,590
-10,380
-2% -$283K
INDA icon
1268
iShares MSCI India ETF
INDA
$6.58B
$13.3M ﹤0.01%
378,700
TECX
1269
Tectonic Therapeutic
TECX
$664M
$13.3M ﹤0.01%
50,396
-16,759
-25% -$3.06M
EXPR
1270
DELISTED
Express, Inc.
EXPR
$13.3M ﹤0.01%
155,099
-1,319
-0.8% -$133K
APLS
1271
DELISTED
Apellis Pharmaceuticals
APLS
$13.3M ﹤0.01%
679,888
-38,995
-5% -$613K
FL
1272
DELISTED
Foot Locker
FL
$13.2M ﹤0.01%
217,993
-2,900
-1% -$169K
AAON icon
1273
Aaon
AAON
$7.23B
$13.2M ﹤0.01%
427,262
+6,803
+2% +$179K
RIGL icon
1274
Rigel Pharmaceuticals
RIGL
$762M
$13.1M ﹤0.01%
509,583
+53,321
+12% +$1.22M
VER
1275
DELISTED
VEREIT, Inc.
VER
$13M ﹤0.01%
311,501
-9,342
-3% -$373K

Similar funds

T. Rowe Price Associates's Q1 2019 Portfolio in Review

As of Q1 2019, T. Rowe Price Associates held 2,615 positions worth $680B, up 15% from $591B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

T. Rowe Price Associates withdrew a net $28.8B in Q1 2019, closing 86 positions and reducing 714 holdings. Its most notable exit was Twenty-First Century Fox, Inc. Class B, an estimated $1.55B position sold in full.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, T. Rowe Price Associates opened a new position in Fox Class B worth $420M.

  • T. Rowe Price Associates's largest Q1 2019 buy was Fox Class B: 11,707,204 shares worth $420M.
  • T. Rowe Price Associates added most to Meta Platforms (Facebook) in Q1 2019, an estimated $2.84B increase.
  • T. Rowe Price Associates's biggest Q1 2019 reduction was TotalEnergies, cutting an estimated $25.3B.
  • T. Rowe Price Associates fully exited Twenty-First Century Fox, Inc. Class B in Q1 2019, selling an estimated $1.55B.
  • T. Rowe Price Associates's ten largest holdings make up 21% of its $680B portfolio in Q1 2019.
  • T. Rowe Price Associates opened 56 new positions and closed 86 in Q1 2019.
  • T. Rowe Price Associates's portfolio value rose 15% quarter-over-quarter to $680B.

Based on T. Rowe Price Associates's 13F filing for Q1 2019, filed 15 May 2019.